THURSDAY, June 25 (HealthDay News) — A hormone might be an effective biomarker to help improve treatment of type 2 diabetes, U.S. researchers report.

Adiponectin is a metabolic hormone that regulates a number of processes, including glucose regulation and metabolism of fat for energy production. Previous research has shown an association between adiponectin and insulin sensitivity.

Read  Hormone Could Improve Diabetes Treatment: Biomarker might predict how type 2 patients will respond to drugs, study shows